What is Nektar Therapeutics's net change in cash?

Nektar Therapeutics (NKTR) reported net change in cash of $134.46M in Q1 2026.

How has Nektar Therapeutics's net change in cash changed year-over-year?

Nektar Therapeutics's net change in cash increased by 2609.6% year-over-year, from -$5.36M to $134.46M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Nektar Therapeutics NKTR Net Change in Cash

Net Change in Cash at other companies

AmgenAMGN

$2.91B+192%

Regeneron PharmaceuticalsREGN

-$153.1M-125%

ImmunityBio, Inc.IBRX

$117.04M+241%

Apogee Therapeutics, Inc.APGE

$320.25M+1,018%

ImmunomeIMNM

-$70.79M-162%

Vera TherapeuticsVERA

-$240.37M-540%

Other financials

Income statement

See full

Revenue$10.9M+3.8%

Gross profit$21.8M+2.9%

Operating income-$39.1M+12.3%

Net income-$44.9M+11.7%

EPS (diluted)-$1.82+49.7%

Balance sheet

See full

Cash & equivalents$5.7M-20.0%

Total debt$83.2M-17.1%

Total equity$576.2M+4,094%

Total assets$763.3M+198%

Cash flow

See full

Operating cash flow-$44.3M+9.7%

CapEx$18.0K+800%

Free cash flow-$44.3M+9.7%

Valuation

See full

Market cap$2.25B+1,531%

Enterprise value$2.33B+874%

P/S40.5×+38.9×

Profitability

See full

Gross margin100%+31.2pp

Operating margin-242%—

Net margin-284.2%+937pp

FCF margin-366.6%+1,421pp

Returns & leverage

See full

Return on equity-53.6%-22.6pp

Debt / equity0.1×-7.2×

Current ratio10.2×+7.0×

Where this comes from

Reported directly by Nektar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nektar Therapeutics's net change in cash?: Nektar Therapeutics (NKTR) reported net change in cash of $134.46M in Q1 2026.
How has Nektar Therapeutics's net change in cash changed year-over-year?: Nektar Therapeutics's net change in cash increased by 2609.6% year-over-year, from -$5.36M to $134.46M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.